Babies almost all try crawling to get from Point A to Point B, but CDC says it’s not a useful developmental milestone

CC BY-ND”>

Babies almost all try crawling to get from Point A to Point B, but CDC says it's not a useful developmental milestone

A new study is collecting crawling biomechanic data using a pressure-sensing pathway. Credit: Mark Geil, CC BY-ND

Infant milestones can be a source both of pride and anxiety for a new parent. Baby’s firsts—first tooth, first steps, first word—are moments of joy that many parents immediately compare with charts listing “normal” age ranges for each achievement to occur.

For a pediatrician, these milestones are useful indicators of typical or atypical development. When they occur outside that normal range, it might be time to look for some underlying cause, which could enable early detection and intervention if something’s amiss.

Since 2004, the U.S. Centers for Disease Control and Prevention has published a set of milestone checklists as part of its “Learn the Signs. Act Early” program. Important skills are listed for a series of ages, enabling anxious parents to know whether baby is developing typically.

In early 2022, the CDC published a major update to the milestones. The new version has a much stronger basis in research evidence and has attempted to simplify language and help caregivers know when to contact a health care provider. Among all the changes, a major milestone was removed. Crawling no longer appears in the milestone checklists.

Crawling to get from here to there

As infants develop awareness of the world around them, they naturally start wanting to explore it. Mobility is the gateway to that exploration. Crawling is typically an infant’s first efficient strategy to get from Point A to Point B, and it often means that new parents must suddenly baby-proof their home and make sure all the Point Bs are safe.

Crawling is a transitional phase of mobility—children and adults are capable of crawling but choose to walk if they’re able to do so—and it often overlaps with precursors to walking such as pulling-to-stand and “cruising” while holding on to furniture.

Studies have indicated that over 80% of infants progress through hands-and-knees crawling during development of locomotion. Others use alternative crawling strategies like scooting along on their bottoms, or rolling.

The World Health Organization studied hundreds of children around the world and found that, on average, children develop hands-and-knees crawling by 8.5 months of age. But that’s just an average. Of course babies each develop on their own schedule. The range for starting to crawl (the 1st percentile to the 99th) was 5.2 to 13.5 months. And 4.3% of the babies in the study skipped hands-and-knees crawling altogether.

Clinicians who work with children have long recognized the importance of motor development. Scientists have called motor behaviors the “raw material for perception, cognition, and social interaction.” In particular, crawling can be an early window to understanding a child’s problem-solving strategies. And researchers have used movement analysis at 4-6 months, when some babies are getting close to hands-and-knees crawling, for early diagnosis of disorders such as autism and .

Therapists worry that removing crawling from the milestone list means it will be devalued and the important physical, sensory and cognitive benefits it affords for the baby will be missed when evaluating childhood development.

Off the evidence-based list of milestones

Much of the CDC’s reasoning for removing crawling from the milestone list is centered on data.

Pediatricians have charts that say how fast children typically walk based on their age, but no such normative data exists for crawling. There are no clear, laboratory-based descriptions of the various types of crawling. We lack that show when babies transition between patterns. And there are very few studies on the implications of skipping crawling and going straight to walking.

Despite these data gaps, crawling has been studied for nearly a century, and researchers have used it to understand the complex development of multiple neuromotor systems. Crawling is also important in understanding developmental continuity, or where new skills grow from.

Nonetheless, the CDC is correct: There are no age-based normative data charts for crawling as there are for walking.

Locomotion in the lab

As a who specializes in pediatric locomotion biomechanics, I have firsthand knowledge of this lack of crawling data.

I’ve used a technique called 3D motion analysis for decades to gather minute details on the walking of children with limb loss, cerebral palsy and other neuromotor conditions, all in an effort to help improve their mobility. My colleagues and I attach small markers to skeletal landmarks like hips and knees, and special cameras track the markers and reconstruct skeletal movement.

But among all my lab’s studies on walking, I’ve completed only one 3D motion analysis study on crawling. We examined the motion of very young children with limb loss in a new prosthetic treatment protocol developed here at Children’s Healthcare of Atlanta—but it was really tricky to do.

We had to create new musculoskeletal models for our analysis system. We had to use tiny reflective markers, because babies make more contact with the ground than older kids, and a big marker might be uncomfortable. We had to position cameras at new angles to track those tiny markers. Diapers created a big challenge, given their movement relative to the baby’s skeleton.

And as any parent or caregiver can attest, babies can be a tough population to work with. They don’t follow directions well, they’re temperamental, and they’ll pull a reflective marker off their skin and pop it in their mouth in a second if you let them. We had to watch our study subjects like hawks.

In short, crawling is just more difficult to study than walking.

Collecting crawling data

To address this challenge, my colleagues and I are now embarking on what we believe is the largest lab-based study of infant crawling development. We’re studying babies from their first crawling attempts all the way through their transition to walking.

This study relies on a new technique with a pressure-sensing pathway that avoids the complications of 3D motion capture. We’ll see 75 typically developing infants, and also study children with limb loss and cerebral palsy.

Our goal is to gain insights into how children transition from crawling to walking, with the hope they will one day help health care providers understand early motor development and spot neuromotor issues earlier.

We’re also hopeful that these hundreds of visits to the lab will result in the first normative data set on crawling development, addressing some of the issues that prompted the CDC to remove crawling from the milestone list. So, while our lab stays full of toys, Cheerios and baby wipes for a few years, we’re generating data that might improve parents’ and clinicians’ understanding of early motor development.

This article is republished from The Conversation under a Creative Commons license. Read the original article.The Conversation

Citation:
Babies almost all try crawling to get from Point A to Point B, but CDC says it’s not a useful developmental milestone (2023, August 9)
retrieved 30 September 2023
from https://medicalxpress.com/news/2023-08-babies-cdc-developmental-milestone.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
New study uncovers key mechanisms responsible for the transformation of adult progenitors into brain tumors thumbnail

New study uncovers key mechanisms responsible for the transformation of adult progenitors into brain tumors

Cultured p53 null OPC over-expressing PDGF-BB are highly proliferative and tend to aggregate in low-adhesion conditions. Credit: Neoplasia (2024). DOI: 10.1016/j.neo.2024.101042 A new study from researchers with the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) sheds light on why certain oligodendrocyte progenitor cells (OPCs) in the adult brain transform into gliomas
Read More
Age when periods first start and early menopause linked to heightened COPD risk thumbnail

Age when periods first start and early menopause linked to heightened COPD risk

Credit: Unsplash/CC0 Public Domain A range of reproductive factors, including the age when periods first start and early menopause, are all linked to a heightened risk of COPD—the umbrella term for progressive lung conditions that cause breathing difficulties—finds research published online in the journal Thorax. Miscarriage, stillbirth, infertility, and having 3 or more children are
Read More
Omicron sub-variant found in 57 countries: WHO thumbnail

Omicron sub-variant found in 57 countries: WHO

Credit: Pixabay/CC0 Public Domain A sub-variant of the highly contagious Omicron coronavirus strain, which some studies indicate could be even more infectious than the original version, has been detected in 57 countries, the WHO said Tuesday. The fast-spreading and heavily mutated Omicron variant has rapidly become the dominant variant worldwide since it was first detected…
Read More
Curious About Running and Weight? Here’s What You Should Know. thumbnail

Curious About Running and Weight? Here’s What You Should Know.

“Just because you haven’t lost weight doesn’t mean you’re not reaping the benefits of exercise in some way,” says exercise physiologist Samantha Heller, M.S., R.D.N., adjunct professor of nutrition and health at the University of Bridgeport, and senior clinical nutritionist at NYU Langone Health. “There’s no downside to getting out the door and exercising on…
Read More
טיפול כימותרפי מול טיפול אנדוקריני בסרטן השד thumbnail

טיפול כימותרפי מול טיפול אנדוקריני בסרטן השד

ציון ההישנות על בסיס מבדק של 21 גנים עבור סרטן שד הינו שימושי לצורך ניבוי של תועלת הטיפול הכימותרפי עבור סרטן שד עם קולטנים להורמונים, ללא קולטנים ל-HER-2 וללא מעורבות קשריות לימפה אקסילריות. עבור נשים עם סרטן שד עם מעורבות קשריות לימפה אקסילריות, טרם ידוע אם ציון ההישנות מנבא היטב את התועלת של טיפול כימותרפי…
Read More
Index Of News
Total
0
Share